SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 405 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $6,509,377 | -33.1% | 41,199 | -45.2% | 0.06% | -29.7% |
| Q1 2024 | $9,734,984 | +91.8% | 75,197 | +42.9% | 0.09% | +78.4% |
| Q4 2023 | $5,074,837 | -31.6% | 52,627 | -14.0% | 0.05% | -37.8% |
| Q3 2023 | $7,415,149 | -40.8% | 61,171 | -44.0% | 0.08% | -31.7% |
| Q2 2023 | $12,519,326 | -60.4% | 109,320 | -52.3% | 0.12% | -63.3% |
| Q1 2023 | $31,582,780 | -6.9% | 229,143 | -12.4% | 0.33% | -11.4% |
| Q4 2022 | $33,910,827 | +8.0% | 261,698 | -7.8% | 0.37% | +0.3% |
| Q3 2022 | $31,388,000 | -6.5% | 283,950 | -36.6% | 0.37% | -4.9% |
| Q2 2022 | $33,588,000 | -13.0% | 448,080 | -9.3% | 0.39% | +10.9% |
| Q1 2022 | $38,591,000 | -22.7% | 493,996 | -10.9% | 0.35% | -11.6% |
| Q4 2021 | $49,917,000 | -14.7% | 554,323 | -12.4% | 0.40% | -14.1% |
| Q3 2021 | $58,510,000 | +22.3% | 632,679 | +2.8% | 0.46% | +31.1% |
| Q2 2021 | $47,855,000 | +182.5% | 615,580 | +169.2% | 0.35% | +185.4% |
| Q1 2018 | $16,940,000 | – | 228,640 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 87,180 | $2,581,000 | 3.60% |
| Perceptive Advisors | 1,771,029 | $52,422,000 | 2.99% |
| SPHERA FUNDS MANAGEMENT LTD. | 483,047 | $14,298,000 | 2.80% |
| HealthCor Management, L.P. | 1,550,000 | $45,880,000 | 2.10% |
| Camber Capital Management LP | 1,350,000 | $39,960,000 | 1.62% |
| Tourbillon Capital Partners, L.P. | 1,537,518 | $45,511,000 | 1.17% |
| Elk Creek Partners, LLC | 562,522 | $16,651,000 | 1.02% |
| EMERALD ADVISERS, LLC | 818,705 | $24,234,000 | 1.00% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 604,467 | $17,892,000 | 0.82% |
| Carlson Capital, L.P. | 1,845,702 | $54,633,000 | 0.70% |